From the gut to the heart, a molecular messenger called TMAO — released when intestinal bacteria digest red meat — has been found to disturb the electrical rhythms that keep the heart beating in order. Cleveland Clinic researchers, studying more than 5,000 patients, have traced a direct biological pathway between this dietary byproduct and atrial fibrillation, America's most prevalent heart rhythm disorder. The discovery matters not merely as a scientific finding, but as an invitation to reimagine prevention: rather than waiting for the heart to falter, medicine may soon intervene at the dinne
Gut Bacteria Byproduct Linked to Heart Rhythm Disorder in Cleveland Clinic Study
Atrial fibrillation affects 2.7 million Americans, causing fatigue, palpitations, breathing difficulties, and increased stroke risk.
intervene much earlier through diet
Mark
So this TMAO compound—it's not something the body makes on its own?
Mimi
No, it's produced by bacteria in your gut when they digest certain nutrients. Your own cells can't make it. It's a byproduct of the microbial ecosystem living inside you.
Mark
And the study found that higher TMAO levels predict who gets atrial fibrillation?
Mimi
Not just predict—they showed the mechanism. TMAO actually changes the electrical properties of heart tissue. It's not just a marker; it appears to be part of what causes the problem.
Mark
Why does this matter more than the other risk factors doctors already know about—high blood pressure, obesity, that sort of thing?
Mimi
Because those are hard to reverse quickly. But diet is something a person can change tomorrow. If you can lower TMAO by eating differently, you might prevent the disease entirely instead of managing it after it starts.
Mark
How confident are they that diet actually works? Did they test that?
Mimi
This study didn't test dietary intervention directly. They showed the connection and the mechanism. The next phase would be to see if reducing TMAO through diet actually prevents atrial fibrillation. That's the real question.
Mark
So for someone worried about this, what would they actually do differently?
Mimi
The obvious answer is eat less red meat and fewer processed animal products. But honestly, we don't yet know the precise dietary changes that would meaningfully lower TMAO. That's what needs to be studied next.
Le Pouls
- A compound quietly produced in the gut is now implicated in destabilizing the heart's electrical system, raising urgent questions about what we eat and what it costs us.
- Atrial fibrillation already burdens 2.7 million Americans with fatigue, palpitations, and a significantly elevated stroke risk — and current treatments arrive only after the damage has begun.
- Cleveland Clinic's Dr. Robert Koeth and his team demonstrated that TMAO doesn't merely drift through the bloodstream — it actively rewires how heart cells conduct electrical signals.
- The medical community is now weighing a meaningful pivot: from symptom management through drugs and ablation procedures toward early dietary intervention targeting the gut microbiome.
- TMAO blood testing is already available in clinical settings, positioning this research to move quickly from laboratory insight to practical preventive care.
From the gut to the heart, a molecular messenger called TMAO — released when intestinal bacteria digest red meat — has been found to disturb the electrical rhythms that keep the heart beating in order. Cleveland Clinic researchers, studying more than 5,000 patients, have traced a direct biological pathway between this dietary byproduct and atrial fibrillation, America's most prevalent heart rhythm disorder. The discovery matters not merely as a scientific finding, but as an invitation to reimagine prevention: rather than waiting for the heart to falter, medicine may soon intervene at the dinner table.
Scientists at Cleveland Clinic have uncovered a striking connection between the gut and the heart: a compound called TMAO, produced when intestinal bacteria break down red meat and other animal products, appears to directly alter the heart's electrical behavior, making dangerous rhythm disruptions more likely.
Dr. Robert Koeth and his team reached this conclusion after analyzing blood samples from more than 5,000 patients undergoing cardiac procedures, combined with laboratory experiments on heart cells. Their findings, published in the Journal of Clinical Investigation, show that TMAO is not a passive bystander in the bloodstream — it actively interferes with the electrical environment of the heart, increasing susceptibility to atrial fibrillation.
Atrial fibrillation is the most common heart rhythm disorder in the United States, affecting at least 2.7 million people. It causes the heart's upper chambers to beat erratically, leaving patients exhausted, breathless, and at heightened risk of stroke as blood pools and clots. Existing treatments — rate-controlling medications and procedures like ablation — address the condition only after it has taken hold.
What distinguishes this research is its preventive implication. If TMAO drives the disease process, then reducing its presence through dietary choices — consuming less red meat and processed animal products — could stop atrial fibrillation before it ever begins. TMAO testing is already part of clinical cardiovascular assessment, and researchers are now investigating whether targeted microbiome interventions can lower TMAO levels and protect at-risk patients. If so, the standard approach to one of America's most common heart conditions may be fundamentally rewritten.
Researchers at Cleveland Clinic have identified a molecular pathway that may explain why some people develop irregular heartbeats: a compound produced when gut bacteria break down red meat and other animal products appears to alter the electrical environment of the heart itself.
The compound is called TMAO, short for trimethylamine N-oxide. When you eat certain foods—particularly those rich in animal fats and proteins—your gut microbes metabolize them and release TMAO into the bloodstream. For years, scientists have suspected this molecule plays a role in cardiovascular disease. Now, a new study published in the Journal of Clinical Investigation shows a direct link between elevated TMAO levels and atrial fibrillation, the most common heart rhythm disorder in America.
Dr. Robert Koeth and his team at Cleveland Clinic analyzed blood samples from more than 5,000 patients who were undergoing heart procedures. They also ran laboratory experiments on heart cells to understand the mechanism. What they found was striking: TMAO doesn't just circulate passively in the blood. It actively changes how the heart's electrical system behaves, making abnormal rhythms more likely to occur. The research builds on more than a decade of work at Cleveland Clinic linking TMAO to kidney disease, heart attacks, and strokes.
Atrial fibrillation is no minor condition. At least 2.7 million Americans live with it. The disorder causes the heart's upper chambers to beat chaotically, and patients often experience fatigue, heart palpitations, shortness of breath, and dizziness. The real danger is stroke—irregular heartbeats allow blood to pool and clot. Current treatments focus on managing symptoms: medications to control heart rate, or procedures like ablation, where doctors deliberately scar tissue in the heart to stabilize its electrical signals. These approaches work, but they come late in the disease process, after the problem has already developed.
What makes this research significant is the possibility of intervening much earlier. "Most current treatments for atrial fibrillation focus on managing the condition, but our findings suggest there may be an opportunity to intervene much earlier through diet," Koeth said. If TMAO is a driver of the disease, then reducing TMAO levels through dietary choices—eating less red meat, fewer processed animal products—might prevent atrial fibrillation from developing in the first place. This represents a fundamental shift in how doctors might approach the disease: not waiting for the rhythm to go haywire, but preventing the electrical disruption before it starts.
TMAO testing is already available in clinical practice and has become part of standard cardiovascular risk assessment. The next step is determining whether interventions targeting the gut microbiome—through diet or other means—can actually reduce TMAO levels and prevent atrial fibrillation in people at risk. If they do, the treatment landscape for one of America's most common heart conditions could change dramatically.
Citations marquantes
Most current treatments for atrial fibrillation focus on managing the condition, but our findings suggest there may be an opportunity to intervene much earlier through diet.— Dr. Robert Koeth, Cleveland Clinic
Envie de l'histoire complète ?
Lire l'original sur Mirage News ↗
Health & Medicine